Ocker, Matthias

Publishing since 2002 (Junior)

Has published 35 publications in 9 years

Number of publications published per year by Ocker, Matthias. (Source : PubMed)

Distribution of publications types for Ocker, Matthias. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Biersack B, Effenberger K, Schobert R, Ocker M. Oxazole-bridged combretastatin A analogues with improved anticancer properties.  ChemMedChem  2010;5;3  
•  Di Fazio P, Schneider-Stock R, Neureiter D, Okamoto K, Wissniowski T, Gahr S, Quint K, Meissnitzer M, Alinger B, Montalbano R, Sass G, Hohenstein B, Hahn EG, Ocker M. The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis.  Cellular oncology : the official journal of the International Society for Cellular Oncology  2010  
•  Lehmann E, El-Tantawy WH, Ocker M, Bartenschlager R, Lohmann V, Hashemolhosseini S, Tiegs G, Sass G. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response.  Hepatology  2010;51;2  
•  Kiesslich T, Alinger B, Wolkersdörfer GW, Ocker M, Neureiter D, Berr F. Active Wnt signalling is associated with low differentiation and high proliferation in human biliary tract cancer in vitro and in vivo and is sensitive to pharmacological inhibition.  Int. J. Oncol.  2010;36;1  
•  Vogl TJ, Wissniowski TT, Naguib NN, Hammerstingl RM, Mack MG, Münch S, Ocker M, Strobel D, Hahn EG, Hänsler J. Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases.  Cancer Immunol. Immunother.  2009;58;10  
•  Stintzing S, Ocker M, Hartner A, Amann K, Barbera L, Neureiter D. Differentiation patterning of vascular smooth muscle cells (VSMC) in atherosclerosis.  Virchows Arch.  2009;455;2  
•  Jabari S, Meissnitzer M, Quint K, Gahr S, Wissniowski T, Hahn EG, Neureiter D, Ocker M. Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells in vitro and in vivo.  Int. J. Oncol.  2009;35;1  
•  Okamoto K, Neureiter D, Ocker M. Biomarkers for novel targeted therapies of hepatocellular carcinoma.  Histol. Histopathol.  2009;24;4  
•  Stintzing S, Schmitt C, Ocker M, Ganslmayer M, Zopf S, Gahr S, Hahn EG, Herold C. Liver function under interferon/ribavirin therapy of chronic hepatitis C.  Hepatogastroenterology  2009;56;90  
•  Quint K, Stintzing S, Alinger B, Hauser-Kronberger C, Dietze O, Gahr S, Hahn EG, Ocker M, Neureiter D. The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer.  Pancreatology  2009;9;1-2  

[ See timeline ] [ See all publications ]